Adenosine 2A receptor blockade as an immunotherapy for treatment-refractory renal cell cancer

Lawrence Fong, Andrew Hotson, John D. Powderly, Mario Sznol, Rebecca S. Heist, Toni K. Choueiri, Saby George, Brett G.M. Hughes, Matthew D. Hellmann, Dale R. Shepard, Brian I. Rini, Shivaani Kummar, Amy M. Weise, Matthew J. Riese, Ben Markman, Leisha A. Emens, Daruka Mahadevan, Jason J. Luke, Ginna Laport, Joshua D. BrodyLeonel Hernandez-Aya, Philip Bonomi, Jonathan W. Goldman, Lyudmyla Berim, Daniel J. Renouf, Rachel A. Goodwin, Brian Munneke, Po Y. Ho, Jessica Hsieh, Ian McCaffery, Long Kwei, Stephen B. Willingham, Richard A. Miller

Research output: Contribution to journalArticlepeer-review

206 Scopus citations

Fingerprint

Dive into the research topics of 'Adenosine 2A receptor blockade as an immunotherapy for treatment-refractory renal cell cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences